Top compounds associated with response to TMEM261


Feature Type Standardized
Nominal ANOVA
mRNA PL-DI CTRPv2 pan-cancer AAC -0.004 0.9
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.0049 0.9
mRNA B02 CTRPv2 pan-cancer AAC 0.0045 0.9
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.0041 0.9
mRNA Docetaxel CTRPv2 pan-cancer AAC 0.0057 0.9
mRNA S-Trityl-L-cysteine GDSC1000 pan-cancer AAC -0.0061 0.9
mRNA BRD-K37390332 CTRPv2 pan-cancer AAC -0.0044 0.9
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.0033 0.9
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0037 0.9
mRNA KH-CB19 CTRPv2 pan-cancer AAC 0.005 0.9
Download CSV